Korean Circ J.  2002 Nov;32(11):1019-1024. 10.4070/kcj.2002.32.11.1019.

A Case of Successful Brachytherapy Using Local Delivery of 99mTc-HMPAO for the Recurrent Coronary Stent Restenosis

Affiliations
  • 1The Heart Center, Chonnam National University Hospital, Gwangju, Korea. myungho@chollian.net

Abstract

A percutaneous coronary intervention (PCI) is known to be one of the effective methods for the treatment of coronary artery disease. However, restenosis remains a major limitation of PCI. Recently vascular brachytherapy has been introduced for the prevention of recurrent restenosis following PCI, especially after stenting.We report a case of a 64-year-old man suffering from an acute myocardial infarction due to total occlusion of the proximal right coronary artery (RCA) and critical stenosis in the proximal left circumflex artery (LCX). After successful PCI for RCA occlusion and LCX stenosis, restenosis developed in both arteries on follow-up coronary angiogram. Simple balloon dilation for the proximal RCA edge restenosis, and cutting balloon angioplasty for the instent restenosis, were performed. The follow-up angiogram revealed no restenosis in the RCA or second instent restenosis in the LCX. A vascular brachytherapy using local delivery of 99mTc-HMPAO was performed for this recurrent lesion. A one-year follow-up angiogram, after local radioisotope delivery, revealed a patent stent without restenosis in the LCX.

Keyword

Myocardial infarction; Coronary restenosis; Radioisotopes; Stents

MeSH Terms

Angioplasty, Balloon
Arteries
Brachytherapy*
Constriction, Pathologic
Coronary Artery Disease
Coronary Restenosis
Coronary Vessels
Follow-Up Studies
Humans
Middle Aged
Myocardial Infarction
Percutaneous Coronary Intervention
Radioisotopes
Stents*
Technetium Tc 99m Exametazime*
Radioisotopes
Technetium Tc 99m Exametazime
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr